<DOC>
	<DOCNO>NCT00002406</DOCNO>
	<brief_summary>The purpose study determine two dose level indinavir combine two nucleoside analogue reverse transcriptase inhibitor ( NRTIs ) effect plasma viral load ( level HIV blood ) .</brief_summary>
	<brief_title>A Comparison Two Dose Levels Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors ( NRTIs ) HIV-Infected Patients</brief_title>
	<detailed_description>In open-label study 350 seropositive HIV-1 men woman first stratify accord baseline plasma viral RNA ( less 400 copies/mL v negative plasma viral RNA result ) randomize one two arm : Arm 1 : Indinavir ( 800 mg , q8h ) plus two pre-existing NRTIs . Arm 2 : Indinavir ( 1,200 mg , q12h ) plus two pre-existing NRTIs . Plasma viral RNA measure every 4 week duration 24-week study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : Documented HIV1 seropositive status . CD4 count great 100 cells/mm3 . Parental consent patient 18 .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Indinavir</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
</DOC>